Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Amgen - 42 Year Stock Price History | AMGN

Historical daily share price chart and data for Amgen since 1983 adjusted for splits and dividends. The latest closing stock price for Amgen as of May 30, 2025 is 288.18.
  • The all-time high Amgen stock closing price was 329.11 on September 20, 2024.
  • The Amgen 52-week high stock price is 346.85, which is 20.4% above the current share price.
  • The Amgen 52-week low stock price is 253.30, which is 12.1% below the current share price.
  • The average Amgen stock price for the last 52 weeks is 302.43.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Amgen Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 286.6938 254.9490 324.4920 254.2700 288.1800 12.44%
2024 293.2592 283.8460 329.1120 252.7440 256.2860 -6.77%
2023 234.7975 241.3680 275.3230 201.2850 274.9020 13.46%
2022 224.0643 202.7150 267.8800 197.7610 242.2810 20.43%
2021 203.6112 196.5840 226.4500 177.8460 201.1770 0.89%
2020 198.0202 202.6400 223.3020 154.8990 199.4120 -1.99%
2019 162.9521 157.1800 205.2560 138.3380 203.4590 27.60%
2018 151.9959 140.8370 170.5720 133.1230 159.4490 15.23%
2017 134.0879 116.6690 150.9450 116.6690 138.3710 22.27%
2016 119.2815 119.4240 135.0370 103.9730 113.1700 -7.57%
2015 118.1398 118.2250 131.9110 99.2415 122.4340 3.95%
2014 96.1089 83.9977 126.9130 80.7659 117.7810 42.33%
2013 74.7865 63.4899 85.7366 58.4548 82.7501 34.80%
2012 53.9376 44.7942 64.2163 44.5497 61.3890 36.83%
2011 38.8587 38.4141 45.2344 33.3798 44.8641 18.17%
2010 38.5533 39.9147 42.2797 34.8251 37.9646 -2.95%
2009 37.9750 40.7930 44.5410 31.1946 39.1195 -2.04%
2008 35.3652 32.2250 45.5645 27.6402 39.9355 24.35%
2007 40.0561 47.3002 52.4520 32.1143 32.1143 -32.02%
2006 48.8514 55.5708 55.5708 44.2022 47.2380 -13.38%
2005 48.3713 44.4511 59.5886 39.5551 54.5335 22.93%
2004 40.7310 43.1165 45.7996 36.4433 44.3612 3.82%
2003 42.4907 34.1059 49.4716 33.8017 42.7292 27.82%
2002 34.1556 39.0019 43.2064 21.4856 33.4282 -14.35%
2001 43.0917 43.4795 51.3024 35.6204 39.0296 -11.73%
2000 45.2732 43.5227 53.9388 35.4838 44.2143 6.45%
1999 25.6592 18.5631 44.8626 18.0877 41.5346 129.77%
1998 11.5528 9.3248 18.1309 8.1470 18.0768 93.19%
1997 9.6340 9.4436 11.8208 7.9417 9.3572 -0.46%
1996 10.1152 10.0703 11.3237 8.9034 9.4004 -8.42%
1995 7.0466 5.0352 10.2648 4.8839 10.2648 101.27%
1994 4.1853 4.2464 5.1324 3.0565 5.1000 19.19%
1993 3.6349 6.1048 6.1157 2.7229 4.2788 -29.91%
1992 5.5746 6.4615 6.7208 4.3220 6.1048 -6.77%
1991 3.9052 1.8369 6.5479 1.6640 6.5479 265.05%
1990 1.1382 0.7419 1.8260 0.6447 1.7937 154.10%
1989 0.6318 0.4610 0.8644 0.4592 0.7059 45.19%
1988 0.4406 0.4646 0.5150 0.3710 0.4862 8.87%
1987 0.4645 0.3404 0.6411 0.2341 0.4466 40.93%
1986 0.2914 0.1819 0.4088 0.1801 0.3169 62.93%
1985 0.1105 0.0685 0.2089 0.0667 0.1945 169.76%
1984 0.0791 0.1044 0.1189 0.0522 0.0721 -30.94%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $154.956B $33.424B
Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two next-generation products, Aranesp & Neulasta and also a biosimilar drug, Prolia/Xgeva. The acquisition of Immunex Corp gave Amgen access to the multi-blockbuster drug, Enbrel. Other products are Repatha, Blincyto, Parsabiv, Evenity, Aimovig, Lumakras/Lumykras, Kanjinti, Mvasi & Amgevita biosimilars. Amgen also has a promising pipeline of cancer drugs. It has one of the strongest cash positions in the biotech sector, which could be used to acquire more pipeline assets that could fuel long-term growth. The erythropoiesis-stimulating agents and granulocyte colony-stimulating factor franchise comprise Epogen/Aranesp and Neupogen/Neulasta respectively. Biosimilar drugs are also a key part of Amgen's growth strategy.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $225.866B 16.86
Gilead Sciences (GILD) United States $136.932B 14.22
Vertex Pharmaceuticals (VRTX) United States $113.517B 0.00
Bristol Myers Squibb (BMY) United States $98.254B 6.58
GSK (GSK) United Kingdom $84.654B 10.06
CSL (CSLLY) Australia $77.242B 0.00
Regeneron Pharmaceuticals (REGN) United States $52.933B 12.85
Alnylam Pharmaceuticals (ALNY) United States $39.711B 0.00
Argenex SE (ARGX) Netherlands $35.003B 95.54
BeiGene (ONC) Cayman Islands $24.373B 0.00
BioNTech SE (BNTX) Germany $23.032B 0.00
Biogen (BIIB) United States $19.018B 8.20
Royalty Pharma (RPRX) United States $18.486B 7.81
Genmab (GNMSF) Denmark $13.727B 14.04
Genmab (GMAB) Denmark $13.433B 15.07
Illumina (ILMN) United States $13.019B 24.70
Insmed (INSM) United States $12.701B 0.00
Incyte (INCY) United States $12.594B 95.68
Exelixis (EXEL) United States $11.737B 19.93
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $11.412B 0.00
BioMarin Pharmaceutical (BMRN) United States $11.136B 18.09
Swedish Orphan Biovitrum (BIOVF) Sweden $10.783B 27.54
Exact Sciences (EXAS) United States $10.617B 0.00
Moderna (MRNA) United States $10.272B 0.00
QIAGEN (QGEN) Netherlands $10.032B 19.52
Ascendis Pharma (ASND) Denmark $9.929B 0.00
Roivant Sciences (ROIV) United Kingdom $7.842B 0.00
Bio-Techne Corp (TECH) United States $7.588B 28.30
Revolution Medicines (RVMD) United States $7.339B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $6.913B 0.00
Halozyme Therapeutics (HALO) United States $6.909B 13.22
Bio-Rad Laboratories (BIO.B) United States $6.805B 23.68
Jazz Pharmaceuticals (JAZZ) Ireland $6.663B 6.42
Repligen (RGEN) United States $6.634B 74.26
Blueprint Medicines (BPMC) United States $6.545B 0.00
Telix Pharmaceuticals (TLX) Australia $5.742B 0.00
TG Therapeutics (TGTX) United States $5.574B 146.29
Nuvalent (NUVL) United States $5.358B 0.00
Legend Biotech (LEGN) United States $5.320B 0.00
Axsome Therapeutics (AXSM) United States $5.178B 0.00
Alkermes (ALKS) Ireland $5.048B 13.54
Guardant Health (GH) United States $5.032B 0.00
Zealand Pharma (ZLDPF) Denmark $5.004B 0.00
ADMA Biologics Inc (ADMA) United States $4.736B 35.43
Vaxcyte (PCVX) United States $4.191B 0.00
Akero Therapeutics (AKRO) United States $3.958B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.902B 0.00
Merus (MRUS) Netherlands $3.881B 0.00
PTC Therapeutics (PTCT) United States $3.846B 6.69
Avidity Biosciences (RNA) United States $3.734B 0.00
Cytokinetics (CYTK) United States $3.705B 0.00
Sarepta Therapeutics (SRPT) United States $3.695B 0.00
Krystal Biotech (KRYS) United States $3.640B 28.05
ACADIA Pharmaceuticals (ACAD) United States $3.610B 31.72
SpringWorks Therapeutics (SWTX) United States $3.520B 0.00
Alvotech (ALVO) Luxembourg $3.449B 19.72
Arcellx (ACLX) United States $3.420B 0.00
Zai Lab (ZLAB) China $3.325B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.217B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.134B 0.00
Viking Therapeutics (VKTX) United States $3.010B 0.00
Protagonist Therapeutics (PTGX) United States $2.942B 63.29
Metsera (MTSR) United States $2.807B 0.00
Scholar Rock Holding (SRRK) United States $2.754B 0.00
Immunovant (IMVT) United States $2.522B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.497B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.421B 0.00
ImmunityBio (IBRX) United States $2.348B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.219B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.214B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.202B 0.00
NovoCure (NVCR) Jersey $2.131B 0.00
Apellis Pharmaceuticals (APLS) United States $2.128B 0.00
Ascentage Pharma Group - (AAPG) China $2.126B 0.00
Vericel (VCEL) United States $2.079B 1376.50
Belite Bio (BLTE) United States $2.065B 0.00
Bavarian Nordic (BVNRY) Denmark $2.046B 10.81
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.996B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.981B 13.17
Ligand Pharmaceuticals (LGND) United States $1.972B 0.00
CG Oncology (CGON) United States $1.953B 0.00
Kymera Therapeutics (KYMR) United States $1.930B 0.00
Denali Therapeutics (DNLI) United States $1.923B 0.00
Amicus Therapeutics (FOLD) United States $1.869B 202.33
Agios Pharmaceuticals (AGIO) United States $1.858B 0.00
Certara (CERT) United States $1.843B 34.42
Immunocore Holdings (IMCR) United Kingdom $1.839B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.805B 0.00
Twist Bioscience (TWST) United States $1.756B 0.00
IDEAYA Biosciences (IDYA) United States $1.742B 0.00
Apogee Therapeutics (APGE) United States $1.687B 0.00
Disc Medicine (IRON) United States $1.617B 0.00
Beam Therapeutics (BEAM) United States $1.592B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.554B 0.00
Biohaven (BHVN) United States $1.512B 0.00
Edgewise Therapeutics (EWTX) United States $1.502B 0.00
Adaptive Biotechnologies (ADPT) United States $1.446B 0.00
89BIO (ETNB) United States $1.436B 0.00
Janux Therapeutics (JANX) United States $1.408B 0.00
GRAIL (GRAL) United States $1.382B 0.00
Mesoblast (MESO) Australia $1.360B 0.00
Travere Therapeutics (TVTX) United States $1.334B 0.00
Celldex Therapeutics (CLDX) United States $1.313B 0.00
BGM Group (BGM) China $1.302B 0.00
Liquidia Technologies (LQDA) United States $1.275B 0.00
ANI Pharmaceuticals (ANIP) United States $1.272B 13.11
MannKind (MNKD) United States $1.261B 25.94
Structure Therapeutics (GPCR) United States $1.248B 0.00
Vera Therapeutics (VERA) United States $1.209B 0.00
Pacira BioSciences (PCRX) United States $1.196B 11.38
Novavax (NVAX) United States $1.189B 2.77
Dynavax Technologies (DVAX) United States $1.176B 69.93
Viridian Therapeutics (VRDN) United States $1.136B 0.00
Anbio Biotechnology (NNNN) Germany $1.132B 0.00
Mineralys Therapeutics (MLYS) United States $1.015B 0.00
CureVac (CVAC) Germany $1.003B 4.86
Geron (GERN) United States $0.968B 0.00
MiMedx (MDXG) United States $0.950B 22.96
Arcus Biosciences (RCUS) United States $0.946B 0.00
NeoGenomics (NEO) United States $0.937B 0.00
WAVE Life Sciences (WVE) Singapore $0.926B 0.00
Spyre Therapeutics (SYRE) United States $0.921B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.907B 0.00
Pharvaris (PHVS) Netherlands $0.868B 0.00
Niagen Bioscience (NAGE) United States $0.852B 120.22
Gyre Therapeutics (GYRE) United States $0.850B 226.75
Oculis Holding AG (OCS) Switzerland $0.849B 0.00
CorMedix Inc (CRMD) United States $0.823B 55.18
LENZ Therapeutics (LENZ) United States $0.822B 0.00
Nurix Therapeutics (NRIX) United States $0.810B 0.00
Zymeworks (ZYME) United States $0.795B 0.00
UniQure (QURE) Netherlands $0.793B 0.00
Praxis Precision Medicines (PRAX) United States $0.785B 0.00
Immunome (IMNM) United States $0.762B 0.00
ArriVent BioPharma (AVBP) United States $0.727B 0.00
Nuvation Bio (NUVB) United States $0.721B 0.00
Pharming Group (PHAR) Netherlands $0.721B 0.00
Intellia Therapeutics (NTLA) United States $0.712B 0.00
Replimune (REPL) United States $0.692B 0.00
Vir Biotechnology (VIR) United States $0.683B 0.00
Pharming Group (PHGUF) Netherlands $0.671B 0.00
Immatics (IMTX) Germany $0.655B 0.00
AnaptysBio (ANAB) United States $0.653B 0.00
Trevi Therapeutics (TRVI) United States $0.650B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.647B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Arbutus Biopharma (ABUS) United States $0.644B 0.00
Anavex Life Sciences (AVXL) United States $0.643B 0.00
GH Research (GHRS) Ireland $0.626B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.626B 0.00
Cogent Biosciences (COGT) United States $0.619B 0.00
Sionna Therapeutics (SION) United States $0.604B 0.00
AbCellera Biologics (ABCL) Canada $0.603B 0.00
Iovance Biotherapeutics (IOVA) United States $0.584B 0.00
Oric Pharmaceuticals (ORIC) United States $0.581B 0.00
Keros Therapeutics (KROS) United States $0.575B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.569B 0.00
Dianthus Therapeutics (DNTH) United States $0.559B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.549B 0.00
Arvinas (ARVN) United States $0.526B 0.00
Opthea (OPT) Australia $0.525B 0.00
Stoke Therapeutics (STOK) United States $0.521B 12.08
Cullinan Therapeutics (CGEM) United States $0.510B 0.00
Eton Pharmaceuticals (ETON) United States $0.507B 0.00
Bicara Therapeutics (BCAX) United States $0.504B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.498B 0.00
Upstream Bio (UPB) United States $0.497B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.494B 0.00
Kura Oncology (KURA) United States $0.493B 0.00
Sana Biotechnology (SANA) United States $0.489B 0.00
Tyra Biosciences (TYRA) United States $0.483B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.466B 0.00
Castle Biosciences (CSTL) United States $0.461B 31.31
REGENXBIO (RGNX) United States $0.444B 0.00
PureTech Health (PRTC) United States $0.443B 0.00
Maze Therapeutics (MAZE) United States $0.438B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.425B 0.00
MBX Biosciences (MBX) United States $0.415B 0.00
Humacyte (HUMA) United States $0.414B 0.00
Verastem (VSTM) United States $0.413B 0.00
Septerna (SEPN) United States $0.412B 0.00
MeiraGTx Holdings (MGTX) United States $0.411B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.407B 0.00
Sage Therapeutics (SAGE) United States $0.405B 0.00
Celcuity (CELC) United States $0.403B 0.00
Tectonic Therapeutic (TECX) United States $0.402B 0.00
Zenas BioPharma (ZBIO) United States $0.398B 0.00
ATyr Pharma (ATYR) United States $0.398B 0.00
Erasca (ERAS) United States $0.397B 0.00
Northwest Biotherapeutics (NWBO) United States $0.394B 0.00
Kamada (KMDA) Israel $0.394B 23.62
Benitec Biopharma (BNTC) United States $0.393B 0.00
Precigen (PGEN) United States $0.390B 0.00
Fortrea Holdings (FTRE) United States $0.389B 10.75
Myriad Genetics (MYGN) United States $0.386B 0.00
ITeos Therapeutics (ITOS) United States $0.384B 0.00
Abivax SA (ABVX) France $0.382B 0.00
Fulcrum Therapeutics (FULC) United States $0.371B 0.00
Checkpoint Therapeutics (CKPT) United States $0.371B 0.00
Vigil Neuroscience (VIGL) United States $0.368B 0.00
Olema Pharmaceuticals (OLMA) United States $0.361B 0.00
Rezolute (RZLT) United States $0.352B 0.00
Cytek Biosciences (CTKB) United States $0.351B 0.00
Emergent Biosolutions (EBS) United States $0.343B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.342B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.340B 0.00
Absci (ABSI) United States $0.338B 0.00
Inventiva S.A (IVA) France $0.324B 0.00
Abeona Therapeutics (ABEO) United States $0.319B 0.00
Alpha Teknova (TKNO) United States $0.308B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.306B 0.00
Rapport Therapeutics (RAPP) United States $0.302B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.297B 0.00
XOMA Royalty (XOMA) United States $0.296B 0.00
Aura Biosciences (AURA) United States $0.295B 0.00
Compass Therapeutics (CMPX) United States $0.290B 0.00
Entrada Therapeutics (TRDA) United States $0.288B 9.38
Prima BioMed (IMMP) Australia $0.275B 0.00
Candel Therapeutics (CADL) United States $0.273B 0.00
Cidara Therapeutics (CDTX) United States $0.272B 0.00
Terns Pharmaceuticals (TERN) United States $0.272B 0.00
Astria Therapeutics (ATXS) United States $0.269B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.268B 0.00
Palvella Therapeutics (PVLA) United States $0.267B 0.00
2seventy Bio (TSVT) United States $0.266B 0.00
Tvardi Therapeutics (TVRD) United States $0.265B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.258B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.257B 52.25
Inozyme Pharma (INZY) United States $0.256B 0.00
Allogene Therapeutics (ALLO) United States $0.256B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.256B 0.00
Atea Pharmaceuticals (AVIR) United States $0.254B 0.00
MaxCyte (MXCT) United States $0.253B 0.00
Gossamer Bio (GOSS) United States $0.252B 0.00
Lifecore Biomedical (LFCR) United States $0.251B 0.00
Solid Biosciences (SLDB) United States $0.249B 0.00
Cartesian Therapeutics (RNAC) United States $0.248B 0.00
Prothena (PRTA) Ireland $0.247B 0.00
Ocugen (OCGN) United States $0.244B 0.00
Neurogene (NGNE) United States $0.243B 0.00
Tango Therapeutics (TNGX) United States $0.241B 0.00
Amarin (AMRN) Ireland $0.240B 0.00
Semper Paratus Acquisition (TVGN) United States $0.237B 0.00
Third Harmonic Bio (THRD) United States $0.235B 0.00
Actuate Therapeutics (ACTU) United States $0.233B 0.00
ACELYRIN, INC (SLRN) United States $0.229B 0.00
DBV Technologies S.A (DBVT) France $0.229B 0.00
Foghorn Therapeutics (FHTX) United States $0.227B 0.00
Cardiff Oncology (CRDF) United States $0.227B 0.00
Aardvark Therapeutics (AARD) United States $0.227B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.227B 0.00
GENFIT S.A (GNFT) France $0.225B 0.00
Adherex Technologies (FENC) United States $0.224B 0.00
Annexon (ANNX) United States $0.224B 0.00
CytomX Therapeutics (CTMX) United States $0.214B 5.52
Adocia (ADOCY) France $0.213B 0.00
Design Therapeutics (DSGN) United States $0.212B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.208B 0.00
Innate Pharma S.A (IPHA) France $0.202B 0.00
Nuvectis Pharma (NVCT) United States $0.197B 0.00
CARGO Therapeutics (CRGX) United States $0.196B 0.00
EnGene Holdings (ENGN) Canada $0.196B 0.00
Urogen Pharma (URGN) United States $0.195B 0.00
Inhibrx Biosciences (INBX) United States $0.195B 0.12
Monopar Therapeutics (MNPR) United States $0.194B 0.00
ScPharmaceuticals (SCPH) United States $0.192B 0.00
Codexis (CDXS) United States $0.191B 0.00
BioStem Technologies (BSEM) $0.187B 7.63
Bright Minds Biosciences (DRUG) United States $0.183B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.180B 0.00
Kodiak Sciences (KOD) United States $0.179B 0.00
Instil Bio (TIL) United States $0.177B 0.00
DiaMedica Therapeutics (DMAC) United States $0.176B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.175B 0.00
AC Immune (ACIU) Switzerland $0.172B 0.00
Galena Biopharma (SLS) United States $0.171B 0.00
INmune Bio (INMB) United States $0.170B 0.00
Alumis (ALMS) United States $0.165B 0.00
Puma Biotechnology (PBYI) United States $0.163B 4.26
Anika Therapeutics (ANIK) United States $0.160B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.159B 0.00
Prime Medicine (PRME) United States $0.155B 0.00
Molecular Partners AG (MOLN) Switzerland $0.154B 0.00
Voyager Therapeutics (VYGR) United States $0.152B 0.00
Alpha Cognition (ACOG) Canada $0.149B 0.00
Editas Medicine (EDIT) United States $0.144B 0.00
BioAge Labs (BIOA) United States $0.142B 0.00
Spero Therapeutics (SPRO) United States $0.140B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.139B 0.00
Fate Therapeutics (FATE) United States $0.139B 0.00
TuHURA Biosciences (HURA) United States $0.134B 0.00
Alector (ALEC) United States $0.133B 0.00
Greenwich LifeSciences (GLSI) United States $0.132B 0.00
Compugen (CGEN) Israel $0.131B 0.00
Black Diamond Therapeutics (BDTX) United States $0.125B 36.67
Nkarta (NKTX) United States $0.123B 0.00
Theratechnologies (THTX) Canada $0.122B 0.00
Ventyx Biosciences (VTYX) United States $0.121B 0.00
Rapt Therapeutics (RAPT) United States $0.117B 0.00
Neumora Therapeutics (NMRA) United States $0.116B 0.00
Elicio Therapeutics (ELTX) United States $0.116B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.114B 0.00
Seer (SEER) United States $0.113B 0.00
Invivyd (IVVD) United States $0.112B 0.00
EXoZymes (EXOZ) United States $0.112B 0.00
Kyverna Therapeutics (KYTX) United States $0.110B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.109B 0.00
Sagimet Biosciences (SGMT) United States $0.109B 0.00
Sangamo Therapeutics (SGMO) United States $0.108B 0.00
I-Mab (IMAB) United States $0.107B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.104B 0.00
BioHarvest Sciences (BHST) Canada $0.103B 0.00
Caribou Biosciences (CRBU) United States $0.099B 0.00
Cabaletta Bio (CABA) United States $0.095B 0.00
Contineum Therapeutics (CTNM) United States $0.095B 0.00
Nautilus Biotechnology (NAUT) United States $0.094B 0.00
Agenus (AGEN) United States $0.094B 0.00
HilleVax (HLVX) United States $0.094B 0.00
IO Biotech (IOBT) Denmark $0.094B 0.00
Adagene (ADAG) China $0.091B 0.00
Genelux (GNLX) United States $0.091B 0.00
Coherus BioSciences (CHRS) United States $0.090B 0.00
Coya Therapeutics (COYA) United States $0.089B 0.00
C4 Therapeutics (CCCC) United States $0.089B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.087B 0.00
XBiotech (XBIT) United States $0.087B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.087B 0.00
Entera Bio (ENTX) Israel $0.084B 0.00
23andMe Holding (MEHCQ) United States $0.083B 0.00
Pliant Therapeutics (PLRX) United States $0.083B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.083B 0.00
Jasper Therapeutics (JSPR) United States $0.083B 0.00
Genenta Science S.p.A (GNTA) Italy $0.082B 0.00
Senti Biosciences (SNTI) United States $0.082B 0.00
Cellectis S.A (CLLS) France $0.081B 0.00
TScan Therapeutics (TCRX) United States $0.081B 0.00
Climb Bio (CLYM) United States $0.080B 0.00
Whitehawk Therapeutics (WHWK) United States $0.080B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.078B 0.00
IGM Biosciences (IGMS) United States $0.076B 0.00
Sutro Biopharma (STRO) United States $0.076B 0.00
Tenaya Therapeutics (TNYA) United States $0.075B 0.00
VistaGen Therapeutics (VTGN) United States $0.074B 0.00
Elutia (ELUT) United States $0.074B 0.00
Inovio Pharmaceuticals (INO) United States $0.073B 0.00
ZIVO Bioscience (ZIVO) United States $0.071B 0.00
BeyondSpring (BYSI) United States $0.070B 0.00
Alto Neuroscience (ANRO) United States $0.070B 0.00
Zura Bio (ZURA) United States $0.069B 0.00
MediciNova (MNOV) United States $0.068B 0.00
Adlai Nortye (ANL) Cayman Islands $0.067B 0.00
Immix Biopharma (IMMX) United States $0.065B 0.00
Citius Oncology (CTOR) United States $0.064B 0.00
Immunic (IMUX) United States $0.063B 0.00
PDS Biotechnology (PDSB) United States $0.063B 0.00
CervoMed (CRVO) United States $0.063B 0.00
OKYO Pharma (OKYO) $0.063B 0.00
Exicure (XCUR) United States $0.062B 0.00
Akoya Biosciences (AKYA) United States $0.062B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.062B 0.00
Oncobiologics (OTLK) United States $0.062B 0.00
Seres Therapeutics (MCRB) United States $0.062B 0.00
Immuneering (IMRX) United States $0.062B 0.00
Skye Bioscience (SKYE) United States $0.061B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.061B 0.00
Adicet Bio (ACET) United States $0.059B 0.00
Opus Genetics (IRD) United States $0.059B 0.00
Clearside Biomedical (CLSD) United States $0.059B 0.00
Repare Therapeutics (RPTX) Canada $0.059B 0.00
Ikena Oncology (IKNA) United States $0.057B 0.00
Forte Biosciences (FBRX) United States $0.056B 0.00
Fortress Biotech (FBIO) United States $0.056B 0.00
Xilio Therapeutics (XLO) United States $0.055B 0.00
TELA Bio (TELA) United States $0.055B 0.00
Werewolf Therapeutics (HOWL) United States $0.054B 0.00
Kalaris Therapeutics (KLRS) United States $0.054B 0.00
Biomea Fusion (BMEA) United States $0.054B 0.00
InflaRx (IFRX) Germany $0.054B 0.00
Precision BioSciences (DTIL) United States $0.054B 0.00
Renovaro (RENB) United States $0.053B 0.00
RenovoRx (RNXT) United States $0.051B 0.00
VTv Therapeutics (VTVT) United States $0.051B 0.00
Celularity (CELU) United States $0.051B 0.00
Applied Therapeutics (APLT) United States $0.050B 0.00
Bluebird Bio (BLUE) United States $0.049B 0.00
Shattuck Labs (STTK) United States $0.048B 0.00
Cue Biopharma (CUE) United States $0.048B 0.00
PepGen (PEPG) United States $0.048B 0.00
Quince Therapeutics (QNCX) United States $0.047B 0.00
Artiva Biotherapeutics (ARTV) United States $0.047B 0.00
Connect Biopharma Holdings (CNTB) United States $0.047B 0.00
Atara Biotherapeutics (ATRA) United States $0.047B 0.00
Adverum Biotechnologies (ADVM) United States $0.046B 0.00
Annovis Bio (ANVS) United States $0.046B 0.00
Imunon (IMNN) United States $0.044B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.043B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.043B 0.00
Rein Therapeutics (RNTX) United States $0.043B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.043B 0.00
Mersana Therapeutics (MRSN) United States $0.043B 0.00
Kronos Bio (KRON) United States $0.041B 0.00
CAMP4 Therapeutics (CAMP) United States $0.040B 0.00
Alterity Therapeutics - (ATHE) Australia $0.040B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.039B 0.00
Estrella Immunopharma (ESLA) United States $0.037B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.036B 0.00
Quantum Biopharma (QNTM) Canada $0.036B 0.00
Scilex Holding (SCLX) United States $0.036B 0.00
Pluri (PLUR) Israel $0.035B 0.00
Radiopharm Theranostics - (RADX) Australia $0.035B 0.00
Medicus Pharma (MDCX) United States $0.035B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.034B 0.00
OnKure Therapeutics (OKUR) United States $0.034B 0.00
Lantern Pharma (LTRN) United States $0.033B 0.00
Aligos Therapeutics (ALGS) United States $0.032B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.032B 0.00
Rani Therapeutics Holdings (RANI) United States $0.032B 0.00
AN2 Therapeutics (ANTX) United States $0.032B 0.00
Dyadic (DYAI) United States $0.031B 0.00
Kezar Life Sciences (KZR) United States $0.031B 0.00
Allakos (ALLK) United States $0.030B 0.00
Oncolytics Biotech (ONCY) Canada $0.029B 0.00
Clene (CLNN) United States $0.029B 0.00
Grace Therapeutics (GRCE) Canada $0.028B 0.00
MiNK Therapeutics (INKT) United States $0.028B 0.00
FibroBiologics (FBLG) United States $0.028B 0.00
Passage Bio (PASG) United States $0.027B 0.00
Dare Bioscience (DARE) United States $0.026B 0.00
Cadrenal Therapeutics (CVKD) United States $0.026B 0.00
ALX Oncology Holdings (ALXO) United States $0.026B 0.00
Curis (CRIS) United States $0.026B 0.00
Generation Bio (GBIO) United States $0.025B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.025B 0.00
Tenax Therapeutics (TENX) United States $0.025B 0.00
Vor Biopharma (VOR) $0.025B 0.00
Chemomab Therapeutics (CMMB) Israel $0.025B 0.00
Boundless Bio (BOLD) United States $0.025B 0.00
KALA BIO (KALA) United States $0.024B 0.00
Femasys (FEMY) United States $0.024B 0.00
BioAtla (BCAB) United States $0.024B 0.00
CalciMedica (CALC) United States $0.024B 0.00
ABVC BioPharma (ABVC) United States $0.023B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.023B 0.00
Lisata Therapeutics (LSTA) United States $0.022B 0.00
Advanced Biomed (ADVB) United States $0.022B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.021B 0.00
Q32 Bio (QTTB) United States $0.021B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.021B 0.00
X4 Pharmaceuticals (XFOR) United States $0.020B 0.00
HOOKIPA Pharma (HOOK) United States $0.019B 0.00
Ovid Therapeutics (OVID) United States $0.019B 0.00
Longeveron (LGVN) United States $0.019B 0.00
SAB Biotherapeutics (SABS) United States $0.018B 0.00
Lexaria Bioscience (LEXX) Canada $0.018B 0.00
Elevation Oncology (ELEV) United States $0.018B 0.00
Promis Neurosciences (PMN) Canada $0.017B 0.00
Cingulate (CING) United States $0.017B 0.00
Beyond Air (XAIR) United States $0.016B 0.00
Leap Therapeutics (LPTX) United States $0.016B 0.00
GeoVax Labs (GOVX) United States $0.016B 0.00
Gelteq (GELS) Australia $0.015B 0.00
Cognition Therapeutics (CGTX) United States $0.015B 0.00
Equillium (EQ) United States $0.014B 0.00
NextCure (NXTC) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
IN8bio (INAB) United States $0.013B 0.00
Synlogic (SYBX) United States $0.013B 0.00
Biorestorative Therapies (BRTX) United States $0.013B 0.00
Allarity Therapeutics (ALLR) United States $0.013B 0.00
Abpro Holdings (ABP) United States $0.013B 0.00
Rallybio (RLYB) United States $0.013B 0.00
BRIACELL THERAP (BCTX) Canada $0.013B 0.00
IBio (IBIO) United States $0.013B 0.00
MetaVia (MTVA) United States $0.013B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.012B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.012B 0.00
Bionano Genomics (BNGO) United States $0.012B 0.00
Moleculin Biotech (MBRX) United States $0.012B 0.00
Athira Pharma (ATHA) United States $0.012B 0.00
Bolt Biotherapeutics (BOLT) United States $0.012B 0.00
UNITY Biotechnology (UBX) United States $0.012B 0.00
BioCardia (BCDA) United States $0.011B 0.00
HCW Biologics (HCWB) United States $0.011B 0.00
Aytu BioPharma (AYTU) United States $0.011B 0.00
Hoth Therapeutics (HOTH) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
LakeShore Biopharma (LSB) China $0.010B 0.00
Dogwood Therapeutics (DWTX) United States $0.010B 0.00
Aprea Therapeutics (APRE) United States $0.010B 0.00
GENPREX (GNPX) United States $0.009B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.009B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.009B 0.00
Intensity Therapeutics (INTS) United States $0.009B 0.00
Portage Biotech (PRTG) $0.008B 0.00
BioAffinity Technologies (BIAF) United States $0.008B 0.00
Sensei Biotherapeutics (SNSE) United States $0.008B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
Pasithea Therapeutics (KTTA) United States $0.007B 0.00
BioXcel Therapeutics (BTAI) United States $0.007B 0.00
Avalon GloboCare (ALBT) United States $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
Apollomics (APLM) United States $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
Jade Biosciences (JBIO) United States $0.006B 0.00
Evogene (EVGN) Israel $0.006B 0.00
180 Life Sciences (ATNF) United States $0.006B 0.00
Mustang Bio (MBIO) United States $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
CNS Pharmaceuticals (CNSP) United States $0.006B 0.00
Adial Pharmaceuticals (ADIL) United States $0.005B 0.00
Biofrontera (BFRI) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Onconetix (ONCO) United States $0.005B 0.00
Polyrizon (PLRZ) Israel $0.005B 0.00
Eyenovia (EYEN) United States $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.005B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Novogen (KZIA) Australia $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
Artelo Biosciences (ARTL) United States $0.003B 0.00
VivoSim Labs (VIVS) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Affimed (AFMD) Germany $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Silo Pharma (SILO) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
Capstone Therapeutics (CAPS) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00